ArticleJournal of thoracic disease2017

A closer look at the safety and effectiveness of modern PORT in stage III-N2 non-small cell lung cancer.

Charlotte Billiet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.